homevideos Newshealthcare NewsUK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'

UK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'

The UK regulator MHRA has approved the GSK’s drug for COVID-19 which is basically 'Xevudy' or 'Sotrovimab' which is a monoclonal antibody. The drug is expected to cut hospitalisation and death by 79 percent. Like Molnupiravir, the drug is approved for those with mild to moderate COVID-19, which is at high risk of developing a severe disease.

By Ekta Batra  Dec 2, 2021 2:59:55 PM IST (Published)

The UK regulator MHRA has approved the GSK’s drug for COVID-19 which is known as 'Xevudy' or 'Sotrovimab' which is a monoclonal antibody. The drug is expected to cut hospitalisation and death by 79 percent. Like Molnupiravir, the drug is approved for those with mild to moderate COVID-19, which is at high risk of developing severe disease.